欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
ISSN号:0929-8673
期刊名称:Current Medicinal Chemistry
时间:2011.5
页码:2146-2157
相关项目:克服Gleevec耐药的新型Bcr-Abl激酶抑制剂的研究
作者:
Lu, X. Y.|Cai, Q.|Ding, K.|
同期刊论文项目
克服Gleevec耐药的新型Bcr-Abl激酶抑制剂的研究
期刊论文 14
同项目期刊论文
Pyrimido[4,5-d]pyrimidin-4(1H)-one Derivatives as Selective Inhibitors of EGFR Threonine(790) to Met
Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphos
Recent Advance in the Design of Small Molecular Modulators of Estrogen-Related Receptors
Design, Synthesis, and Biological Evaluation of 3-(1H-1,2,3-Triazol-1-yl)benzamide Derivatives as Po
Hybrid compounds as new Bcr/Abl inhibitors